Skip to main content

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2345${count})

  • Inflammation Biomarkers Program, 2018
    Studying Abnormalities of Immune System Aging in Parkinson's Disease

    Study Rationale:
    While immune cells protect us from infection, they can also cause damage by inadvertently responding to other, non-infectious events. Such immune response occurs in Parkinson's disease...

  • Research Grant, 2018
    Studying Structures of LRRK2 to Understand and Slow Parkinson's Disease

    Study Rationale:
    Mutations in the LRRK2 gene are a leading genetic cause of Parkinson's disease (PD) and cause dysfunction in the LRRK2 protein. We are studying the structures of normal and abnormal...

  • Inflammation Biomarkers Program, 2018
    Influence of Inflammation on Symptoms and Progression of Parkinson's Disease

    Study Rationale:
    Symptoms of Parkinson's disease (PD) are different for different people, suggesting a strong influence of genetic and/or non-genetic factors, including inflammation. While many...

  • Improved Biomarkers and Clinical Outcome Measures, 2018
    The Role of Circular RNAs in Parkinson's Disease and Dementia

    Study Rationale:
    Biomarkers are objectively measurable characteristics that can be used to diagnose a disease or to track its progression. In this study, we will explore circular RNAs -- a recently...

  • Research Grant, 2018
    Inducing Aging in Brain Cells to Better Understand Parkinson's Disease

    Study Rationale:
    Age is the biggest risk factor for Parkinson's disease (PD), with disease incidence rising steeply among persons 60 or older. The reason for this remains unknown. Research suggests...

  • Therapeutic Pipeline Program, 2018
    Developing a Blocker of Alpha-synuclein Production for the Treatment of Parkinson's Disease

    Study Rationale:
    Alpha-synuclein is a sticky protein that clumps in the brains of people with Parkinson's disease (PD). Duplication or triplication of SNCA, a gene responsible for the production of...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.